Mondaq UK: Food, Drugs, Healthcare, Life Sciences
The number of care homes businesses going bust has increased from 35 in 2010 to 67 in 2012, according to accountancy firm, Wilkins Kennedy.
Top tips for those in public office when weathering public scrutiny.
Following publication of the results of the Intellectual Property Office’s consultation on the subject, the Government has announced that the Patents Act shall be amended.
In the case "Brain Products GmbH v BioSemi VOF" the Court of Justice for the European Union has clarified the meaning of ‘medical device’.
In the case of "Glenmark Generics Limited & others v The Wellcome Foundation Limited and Glaxo Group Ltd" the High Court has found that Wellcome's patent for the anti-malarial drug Malarone is invalid and hence should be revoked.
A discussion on the conduct of clinical trial in the European Union.
Leaders from some of the South West’s biggest and most successful industries have come together to draw a road map to the region becoming Britain’s agri-food sector ‘centre of excellence’.
Under the NHS reforms, CCGs now have responsibility for commissioning healthcare services to meet the reasonable needs of the persons for whom they are responsible.
The Law Commission has published a review of the Regulation of Health Care Professionals.
The European Commission has recently submitted a proposal to ban 3 neonicotinoid insecticides to the Standing Committee on the Food Chain and Animal Health.
In February, the Department of Health laid before Parliament the National Health Service (Procurement, Patient Choice and Competition) Regulations 2013.
Yesterday Arnold J handed down a judgment referring yet another SPC question to the CJEU in GlaxoSmithKline Biologicals SA v Comptroller [2013] EWHC 619.
The NHS Pensions Agency has recently confirmed that NHS staff who are outsourced to private sector organisations will be able to continue with their existing NHS pension entitlements.
Welcome to FFW's Public and Regulatory Group Alerter, highlighting the key cases and events taking place in February 2013.
The CR Pharmacy Team’s annual conference will be held on 30 April 2013 at our London office.
The Department of Health is currently in the process of transforming the death certification procedure following recommendations made by the Shipman Inquiry.
The NHS (Charges to Overseas Visitors) Regulations 2011 require every NHS Trust in England to consider whether all patients who are newly referred or attending for a new episode of treatment are entitled to free NHS treatment.
On 1 October 2012 the Government fully implemented the ban on age discrimination
enshrined in the Equality Act 2010.
The Serious Incident Requiring Investigation report is becoming increasingly used in the litigation process.
The recent decision of Mr Justice Males in Noordeen v Hill and the Health Research Authority highlights the need for people to be allowed to express their concerns about medical practitioners to responsible people without fear of litigation.
Most Popular Recent Articles
Under the NHS reforms, CCGs now have responsibility for commissioning healthcare services to meet the reasonable needs of the persons for whom they are responsible.
A discussion on the conduct of clinical trial in the European Union.
We have advised recently on a number of incidents where it is alleged that a doctor was criminally responsible for the death of his/her patient.
In the case "Brain Products GmbH v BioSemi VOF" the Court of Justice for the European Union has clarified the meaning of ‘medical device’.
In the case of "Glenmark Generics Limited & others v The Wellcome Foundation Limited and Glaxo Group Ltd" the High Court has found that Wellcome's patent for the anti-malarial drug Malarone is invalid and hence should be revoked.
The Law Commission has published a review of the Regulation of Health Care Professionals.
Leaders from some of the South West’s biggest and most successful industries have come together to draw a road map to the region becoming Britain’s agri-food sector ‘centre of excellence’.
A discussion on the unsurprising December decision of the Court of Justice of the European Union in the AstraZeneca case.
In February, the Department of Health laid before Parliament the National Health Service (Procurement, Patient Choice and Competition) Regulations 2013.
Following publication of the results of the Intellectual Property Office’s consultation on the subject, the Government has announced that the Patents Act shall be amended.
